# Xenon Pharmaceuticals Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:cca4cc15-364f-4c52-9c39-34f3cf20478a | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/xenon-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 25 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:45:50.140288+00:00 | | Last reviewed | 2026-10-17T04:45:50.140288+00:00 | ## Identity - Legal name: Xenon Pharmaceuticals Inc. - Display name: Xenon Pharmaceuticals Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T04:45:50.140288+00:00 | | Completeness | 0.409 | | Record Quality | 0.829 | | Directors | 13 | | Committees | 2 | | Governance events | 9 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Ann Arbor: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:7 - Baie D’Urfe: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:8 - Darren Cline: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-22. Committees: Compensation and Benefits Committee (member). claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:9 - Gillian Cannon: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:12 - Justin Gover: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:14 - Los Altos Hills: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2004-01-01. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:15 - North Vancouver: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:16 - Patrick Machado: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:17 - Steven Gannon: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:18 - Dawn A. Svoronos: Chair of the Board and Lead Independent Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:6 - Elizabeth Garofalo: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:10 - Gary Patou: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:11 - Ian C. Mortimer: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:13 ## Committees - Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: Ian C. Mortimer (member, unknown). committee_id=alpha:committee:xenon-pharmaceuticals-inc:chief-executive-officer-and-director - Compensation and Benefits Committee (compensation). Chair: NOT_PUBLISHED. Members: Darren Cline (member, current). committee_id=alpha:committee:xenon-pharmaceuticals-inc:compensation-and-benefits-committee ## Executive leadership - Andrea DiFabio: Chief Legal Officer and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:19 - Christopher Kenney: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:20 - Darren Cline: Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:21 - Ian C. Mortimer: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:22 - Thomas Kelly: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:23 ## Governance events - DIRECTOR_APPOINTED: Darren Cline seat on Xenon Pharmaceuticals Inc., effective 2026-04-22. Effective: 2026-04-22. Detected: 2026-10-17T04:45:50.140288+00:00. event_id=alpha:event:transition:nfv4ry1e4tzfe - DIRECTOR_APPOINTED: Gillian Cannon seat on Xenon Pharmaceuticals Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:50.140288+00:00. event_id=alpha:event:transition:1av7gqx1akcu4p - DIRECTOR_APPOINTED: Justin Gover seat on Xenon Pharmaceuticals Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:50.140288+00:00. event_id=alpha:event:transition:u5kqhp13mw18r - DIRECTOR_APPOINTED: Steven Gannon seat on Xenon Pharmaceuticals Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:45:50.140288+00:00. event_id=alpha:event:transition:1co0yik2vdrv2 - DIRECTOR_APPOINTED: Ann Arbor seat on Xenon Pharmaceuticals Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:50.140288+00:00. event_id=alpha:event:transition:1ohq0251a5ishv - DIRECTOR_APPOINTED: North Vancouver seat on Xenon Pharmaceuticals Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:50.140288+00:00. event_id=alpha:event:transition:ngi8i5nxsu4b - DIRECTOR_APPOINTED: Patrick Machado seat on Xenon Pharmaceuticals Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:45:50.140288+00:00. event_id=alpha:event:transition:1izqp2v10gbmrb - DIRECTOR_APPOINTED: Baie D’Urfe seat on Xenon Pharmaceuticals Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-17T04:45:50.140288+00:00. event_id=alpha:event:transition:1vl3bqeeoukeo - DIRECTOR_APPOINTED: Los Altos Hills seat on Xenon Pharmaceuticals Inc., effective 2004-01-01. Effective: 2004-01-01. Detected: 2026-10-17T04:45:50.140288+00:00. event_id=alpha:event:transition:16wvfer16pp0f7 ## Scoped resources - `alpha://company/xenon-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record - `alpha://company/xenon-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/xenon-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/xenon-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=board - `alpha://company/xenon-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/xenon-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/xenon-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/xenon-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/xenon-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/xenon-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/xenon-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/xenon-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/xenon-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/xenon-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/xenon-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/xenon-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/xenon-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/xenon-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/xenon-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/xenon-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=events - `alpha://company/xenon-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/xenon-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/xenon-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Compensation and Benefits Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:darren-cline","name":"Darren Cline"},"source_id":"governance_people_committees"}` ## Leadership - Dawn A. Svoronos: Chair of the Board and Lead Independent Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02a17950c47551f018bd8280284538d669b6477a9504b12df86f46b43be74dfc. - Ann Arbor: Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:7. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:60991e51b1b3159f622446210ef6534df2b46763df60fca1b68da36300cd46b1. - Baie D’Urfe: Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:8. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:60991e51b1b3159f622446210ef6534df2b46763df60fca1b68da36300cd46b1. - Darren Cline: Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:9. Valid from: 2026-04-22. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:60991e51b1b3159f622446210ef6534df2b46763df60fca1b68da36300cd46b1. - Elizabeth Garofalo: Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02a17950c47551f018bd8280284538d669b6477a9504b12df86f46b43be74dfc. - Gary Patou: Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02a17950c47551f018bd8280284538d669b6477a9504b12df86f46b43be74dfc. - Gillian Cannon: Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:12. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:60991e51b1b3159f622446210ef6534df2b46763df60fca1b68da36300cd46b1. - Ian C. Mortimer: President, Chief Executive Officer and Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02a17950c47551f018bd8280284538d669b6477a9504b12df86f46b43be74dfc. - Justin Gover: Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:14. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:60991e51b1b3159f622446210ef6534df2b46763df60fca1b68da36300cd46b1. - Los Altos Hills: Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:15. Valid from: 2004-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:60991e51b1b3159f622446210ef6534df2b46763df60fca1b68da36300cd46b1. - North Vancouver: Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:16. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:60991e51b1b3159f622446210ef6534df2b46763df60fca1b68da36300cd46b1. - Patrick Machado: Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:17. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:60991e51b1b3159f622446210ef6534df2b46763df60fca1b68da36300cd46b1. - Steven Gannon: Director. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:18. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:60991e51b1b3159f622446210ef6534df2b46763df60fca1b68da36300cd46b1. - Andrea DiFabio: Chief Legal Officer and Corporate Secretary. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02a17950c47551f018bd8280284538d669b6477a9504b12df86f46b43be74dfc. - Christopher Kenney: Chief Medical Officer. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02a17950c47551f018bd8280284538d669b6477a9504b12df86f46b43be74dfc. - Darren Cline: Chief Commercial Officer. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02a17950c47551f018bd8280284538d669b6477a9504b12df86f46b43be74dfc. - Ian C. Mortimer: President and Chief Executive Officer. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02a17950c47551f018bd8280284538d669b6477a9504b12df86f46b43be74dfc. - Thomas Kelly: Chief Financial Officer. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02a17950c47551f018bd8280284538d669b6477a9504b12df86f46b43be74dfc. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Compensation and Benefits Committee: Chair not stated; Members Darren Cline. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c17bb5ec618fe7b8b9a4b7db138783f029a1c2259acc0b4b019ecf0f7c8b8ed2. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Xenon Pharmaceuticals Inc.. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d8355da06062e638ae59a5b49b427f3292af6985c0fe11e6768fbceee99a4d16. ## Entity Status - Public listing published. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d8355da06062e638ae59a5b49b427f3292af6985c0fe11e6768fbceee99a4d16. ## Published Fact - US. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d8355da06062e638ae59a5b49b427f3292af6985c0fe11e6768fbceee99a4d16. - Healthcare. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d8355da06062e638ae59a5b49b427f3292af6985c0fe11e6768fbceee99a4d16. ## Committee Appointment - Darren Cline: member, Compensation and Benefits Committee. Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c17bb5ec618fe7b8b9a4b7db138783f029a1c2259acc0b4b019ecf0f7c8b8ed2. ## Security Listing - XENE (NASDAQ). Claim: alpha:claim:company:cca4cc15-364f-4c52-9c39-34f3cf20478a:security_listing:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d8355da06062e638ae59a5b49b427f3292af6985c0fe11e6768fbceee99a4d16. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:d8355da06062e638ae59a5b49b427f3292af6985c0fe11e6768fbceee99a4d16: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc). - alpha:projection-evidence:document:02a17950c47551f018bd8280284538d669b6477a9504b12df86f46b43be74dfc: [SEC DEF 14A 0001193125-26-170320](https://www.sec.gov/Archives/edgar/data/1582313/000119312526170320/xene-20260422.htm). - alpha:projection-evidence:document:60991e51b1b3159f622446210ef6534df2b46763df60fca1b68da36300cd46b1: [DEF 14A xene-20260422.htm](https://www.sec.gov/Archives/edgar/data/1582313/000119312526170320/xene-20260422.htm). - alpha:projection-evidence:c17bb5ec618fe7b8b9a4b7db138783f029a1c2259acc0b4b019ecf0f7c8b8ed2: [Compensation and Benefits Committee](https://www.sec.gov/Archives/edgar/data/1582313/000119312526170320/xene-20260422.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/xenon-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/xenon-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/xenon-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/xenon-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-17T06:29:03.73365+00:00; recorded 2026-10-17T06:29:03.73365+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.